Skip to main content Help with accessibility Skip to main navigation

ERTUGLIFLOZIN film-coated tablets (Steglatro®▼) in a triple therapy regimen for treating type 2 diabetes

CCG Approval Status:

Date Added: 26 - Jun - 2019
Body System:
Green

The Pan Mersey Area Prescribing Committee recommends the prescribing of ERTUGLIFLOZIN film-coated tablets (Steglatro®▼) in a triple therapy regimen for treating type 2 diabetes in accordance with NICE TA583.